Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ: OBIO · Real-Time Price · USD
5.95
-0.40 (-6.30%)
Oct 2, 2026, 4:00 PM EDT - Market closed
Orchestra BioMed Holdings Market Cap
Orchestra BioMed Holdings has a market cap or net worth of $357.63 million as of October 2, 2026. Its market cap has increased by 159.93% in one year.
Market Cap
357.63M
Enterprise Value
318.42M
1-Year Change
159.93%
Ranking
Category
Stock Price
$5.95
ChartMarket Cap Chart
Since August 4, 2020, Orchestra BioMed Holdings's market cap has increased from $197.44M to $357.63M, an increase of 81.13%. That is a compound annual growth rate of 10.12%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 357.63M | 52.62% |
| Dec 31, 2025 | 234.33M | 54.11% |
| Dec 31, 2024 | 152.05M | -53.41% |
| Dec 29, 2023 | 326.34M | 191.65% |
| Dec 30, 2022 | 111.90M | -45.72% |
| Dec 31, 2021 | 206.14M | -21.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 4, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Turn Therapeutics | 396.48M |
| vTv Therapeutics | 395.73M |
| Relmada Therapeutics | 390.41M |
| Prelude Therapeutics | 390.35M |
| Editas Medicine | 387.02M |
| C4 Therapeutics | 386.30M |
| Galectin Therapeutics | 379.19M |
| Arcturus Therapeutics Holdings | 375.47M |